These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
245 related items for PubMed ID: 23595400
1. Intravitreal injection of melphalan in the treatment of retinoblastoma with vitreous cavity seeding. Sun YB, Hui P, Punyara K, Bi MC, Li SH, Teng SY, Song E. Chin Med J (Engl); 2013; 126(8):1587. PubMed ID: 23595400 [No Abstract] [Full Text] [Related]
6. Not All Seeds Are Created Equal: Seed Classification Is Predictive of Outcomes in Retinoblastoma. Berry JL, Bechtold M, Shah S, Zolfaghari E, Reid M, Jubran R, Kim JW. Ophthalmology; 2017 Dec; 124(12):1817-1825. PubMed ID: 28655537 [Abstract] [Full Text] [Related]
7. Combined intravitreal melphalan and intravenous/intra-arterial chemotherapy for retinoblastoma with vitreous seeds. Lee JH, Han JW, Hahn SM, Lyu CJ, Kim DJ, Lee SC. Graefes Arch Clin Exp Ophthalmol; 2016 Feb; 254(2):391-4. PubMed ID: 26511530 [Abstract] [Full Text] [Related]
8. Intravitreal chemotherapy for vitreous disease in retinoblastoma revisited: from prohibition to conditional indications. Munier FL, Gaillard MC, Balmer A, Soliman S, Podilsky G, Moulin AP, Beck-Popovic M. Br J Ophthalmol; 2012 Aug; 96(8):1078-83. PubMed ID: 22694968 [Abstract] [Full Text] [Related]
9. Pathological findings in enucleated eyes after intravitreal melphalan injection. Ghassemi F, Amoli FA. Int Ophthalmol; 2014 Jun; 34(3):533-40. PubMed ID: 24043335 [Abstract] [Full Text] [Related]
14. INTRAVITREOUS CHEMOTHERAPY FOR ACTIVE VITREOUS SEEDING FROM RETINOBLASTOMA: Outcomes After 192 Consecutive Injections. The 2015 Howard Naquin Lecture. Shields CL, Douglass AM, Beggache M, Say EA, Shields JA. Retina; 2016 Jun; 36(6):1184-90. PubMed ID: 26630319 [Abstract] [Full Text] [Related]
15. Combined intravitreal melphalan and topotecan for refractory or recurrent vitreous seeding from retinoblastoma. Ghassemi F, Shields CL, Ghadimi H, Khodabandeh A, Roohipoor R. JAMA Ophthalmol; 2014 Aug; 132(8):936-41. PubMed ID: 24789622 [Abstract] [Full Text] [Related]
16. Intraocular Pressure Changes Following Intravitreal Melphalan and Topotecan for the Treatment of Retinoblastoma With Vitreous Seeding. Karl MD, Francis JH, Iyer S, Marr B, Abramson DH. J Pediatr Ophthalmol Strabismus; 2017 May 01; 54(3):185-190. PubMed ID: 28092395 [Abstract] [Full Text] [Related]
17. Diffuse chorioretinal atrophy after a single standard low- dose intravitreal melphalan injection in a child with retinoblastoma: a case report. Chao A, Kao LY, Liu L, Wang NK. BMC Ophthalmol; 2016 Mar 15; 16():27. PubMed ID: 26975871 [Abstract] [Full Text] [Related]
18. Intravitreal chemotherapy provides control for massive vitreous seeding from retinoblastoma. Lawson BM, Saktanasate J, Say EA, Shields CL. J Pediatr Ophthalmol Strabismus; 2014 Dec 12; 51 Online():e92-4. PubMed ID: 25490242 [Abstract] [Full Text] [Related]
19. Intravitreal melphalan hydrochloride vs propylene glycol-free melphalan for retinoblastoma vitreous seeds: Efficacy, toxicity and stability in rabbits models and patients. Bogan CM, Pierce JM, Doss SD, Tao YK, Chen SC, Boyd KL, Liao A, Hsieh T, Abramson DH, Francis JH, Friedman DL, Richmond A, Daniels AB. Exp Eye Res; 2021 Mar 12; 204():108439. PubMed ID: 33444583 [Abstract] [Full Text] [Related]